Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study sheds light on potential new treatment approach in AML patients

Study sheds light on potential new treatment approach in AML patients

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Multiple, intertwined cell death systems to prevent the spread of 'intracellular' bacteria

Study finds fungal isolates with high levels of virulence in different hospitals

Study finds fungal isolates with high levels of virulence in different hospitals

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Stand Up To Cancer announces $1.1 million in funding to foster collaborative research

Stand Up To Cancer announces $1.1 million in funding to foster collaborative research

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Combining two immunotherapies into a single treatment found to be more effective

Combining two immunotherapies into a single treatment found to be more effective

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Researchers identify specific target sites for DNA methylases

Researchers identify specific target sites for DNA methylases

GlobalData: Hematology tests can be a prognostic marker to predict severity of COVID-19 patients

GlobalData: Hematology tests can be a prognostic marker to predict severity of COVID-19 patients

Experimental therapy slows zika replication and prevents microcephaly in mice

Experimental therapy slows zika replication and prevents microcephaly in mice

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

Rare inherited mutation in TP53 gene confers risk of multiple cancers

Rare inherited mutation in TP53 gene confers risk of multiple cancers

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

Cancer drug could help inhibit adenovirus infection

Cancer drug could help inhibit adenovirus infection

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

New cancer vaccine shows promising signs in preclinical studies

New cancer vaccine shows promising signs in preclinical studies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

Mapping immune landscape of hematological malignancies may help improve cancer therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.